{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:51:33Z","timestamp":1790632293886,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["223273"],"award-info":[{"award-number":["223273"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"name":"South East Norway Health Authority","award":["2017-112"],"award-info":[{"award-number":["2017-112"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.pnpbp.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T21:16:23Z","timestamp":1510002983000},"page":"263-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Side effect burden of antipsychotic drugs in real life \u2013 Impact of gender and polypharmacy"],"prefix":"10.1016","volume":"82","author":[{"given":"Trude Seselie Jahr","family":"Iversen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Eiel","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Dieset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrun","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragni","family":"M\u00f8rch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlend Strand","family":"Gardsjord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil Nordb\u00f8","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Melle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen","family":"Molden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik G.","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2017.11.004_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1995"},{"key":"10.1016\/j.pnpbp.2017.11.004_bb0010","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.1961.03040120016004","article-title":"A survey of drug-induced extrapyramidal reactions","volume":"175","author":"Ayd","year":"1961","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.11.004_bb0015","doi-asserted-by":"crossref","first-page":"e94112","DOI":"10.1371\/journal.pone.0094112","article-title":"Almost all antipsychotics result in weight gain: a meta-analysis","volume":"9","author":"Bak","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pnpbp.2017.11.004_bb0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.jcp.0000185423.15891.02","article-title":"Sex differences in the subjective tolerability of antipsychotic drugs","volume":"25","author":"Barbui","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2017.11.004_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/11587810-000000000-00000","article-title":"Antipsychotic polypharmacy in schizophrenia: benefits and risks","volume":"25","author":"Barnes","year":"2011","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.11.004_bb0030","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/138920009788498996","article-title":"Gender differences in p-glycoprotein expression and function: effects on drug disposition and outcome","volume":"10","author":"Bebawy","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.pnpbp.2017.11.004_bb0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0447.2008.01310.x","article-title":"Side-effects of antipsychotic medication and health-related quality of life in schizophrenia","volume":"438","author":"Bebbington","year":"2009","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"5","key":"10.1016\/j.pnpbp.2017.11.004_bb0040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra035354","article-title":"Bipolar disorder","volume":"351","author":"Belmaker","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2017.11.004_bb0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-244X-11-126","article-title":"Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophrenia","volume":"11","author":"Bolstad","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.11.004_bb0050","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1176\/appi.ajp.161.4.700","article-title":"Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits","volume":"161","author":"Centorrino","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.11.004_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/wps.20204","article-title":"Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2017.11.004_bb0060","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1192\/bjp.166.5.650","article-title":"A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients","volume":"166","author":"Day","year":"1995","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.11.004_bb0065","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.neuropharm.2011.03.013","article-title":"Psychopharmacological treatment of schizophrenia: what do we have, and what could we get?","volume":"62","author":"Ellenbroek","year":"2012","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.11.004_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00004850-200105000-00004","article-title":"Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline","volume":"16","author":"Fakhoury","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.11.004_bb0075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1017\/S0033291700036539","article-title":"Subjective utility ratings of neuroleptics in treating schizophrenia","volume":"20","author":"Finn","year":"1990","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.11.004_bb0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14740338.2012.683523","article-title":"Safety and tolerability of antipsychotic polypharmacy","volume":"11","author":"Gallego","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"issue":"8","key":"10.1016\/j.pnpbp.2017.11.004_bb0085","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1517\/14740338.2015.1053457","article-title":"Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis","volume":"14","author":"Galling","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2017.11.004_bb0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.schres.2007.09.002","article-title":"Antipsychotic polypharmacy does not increase the risk for side effects","volume":"98","author":"Ganesan","year":"2008","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.11.004_bb0095","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1176\/appi.ajp.161.4.692","article-title":"Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia","volume":"161","author":"Gilmer","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2017.11.004_bb0100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jopan.2014.09.001","article-title":"Antiemetics: focus on pharmacology","volume":"29","author":"Golembiewski","year":"2014","journal-title":"J. Perianesth. Nurs."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.11.004_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.11.004_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression","volume":"11","author":"Grunze","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2017.11.004_bb0115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0013-7006(04)95457-7","article-title":"Comparison of two assessment tools of antidepressant side-effects: UKU scale versus spontaneous notification","volume":"30","author":"Gruwez","year":"2004","journal-title":"L'Enc\u00e9phale"},{"issue":"9","key":"10.1016\/j.pnpbp.2017.11.004_bb0120","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2217\/pgs.09.102","article-title":"Sex-specific differences in side effects of psychotropic drugs: genes or gender?","volume":"10","author":"Haack","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"13","key":"10.1016\/j.pnpbp.2017.11.004_bb0125","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.1980.03310130038026","article-title":"Epileptogenic side effects of psychotropic drugs. Practical recommendations","volume":"244","author":"Itil","year":"1980","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.11.004_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0447.2012.01911.x","article-title":"Predictors of medication adherence in patients with schizophrenia and bipolar disorder","volume":"127","author":"Jonsdottir","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2017.11.004_bb0135","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2147\/NDT.S84528","article-title":"The influence of atypical antipsychotic drugs on sexual function","volume":"11","author":"Just","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.11.004_bb0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"4\u20135","key":"10.1016\/j.pnpbp.2017.11.004_bb0145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/hup.1205","article-title":"Reliability and validity of a new sexual function questionnaire (Nagoya Sexual Function Questionnaire) for schizophrenic patients taking antipsychotics","volume":"26","author":"Kikuchi","year":"2011","journal-title":"Human Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.11.004_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","article-title":"Antipsychotic medication in schizophrenia: a review","volume":"114","author":"Lally","year":"2015","journal-title":"Br. Med. Bull."},{"issue":"5","key":"10.1016\/j.pnpbp.2017.11.004_bb0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hup.495","article-title":"Measurement of antipsychotic-induced side effects: support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement","volume":"18","author":"Lambert","year":"2003","journal-title":"Human Psychopharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2017.11.004_bb0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.eurpsy.2004.06.031","article-title":"Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence","volume":"19","author":"Lambert","year":"2004","journal-title":"Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.11.004_bb0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1517\/14740338.2.3.233","article-title":"Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings","volume":"2","author":"Lee","year":"2003","journal-title":"Expert Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.11.004_bb0170","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0447.1999.tb00972.x","article-title":"A combined analysis of double-blind studies with risperidone vs. placebo and other antipsychotic agents: factors associated with extrapyramidal symptoms","volume":"99","author":"Lemmens","year":"1999","journal-title":"Acta Psychiatr. Scand."},{"issue":"9657","key":"10.1016\/j.pnpbp.2017.11.004_bb0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet (Lond. Engl.)"},{"issue":"9896","key":"10.1016\/j.pnpbp.2017.11.004_bb0180","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet (Lond. Engl.)"},{"issue":"9659","key":"10.1016\/j.pnpbp.2017.11.004_bb0185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(09)60072-6","article-title":"Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study","volume":"373","author":"Lichtenstein","year":"2009","journal-title":"Lancet (Lond. Engl.)"},{"issue":"12","key":"10.1016\/j.pnpbp.2017.11.004_bb0190","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2017.11.004_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.11.004_bb0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0269881113477709","article-title":"Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness","volume":"27","author":"Lochmann van Bennekom","year":"2013","journal-title":"J. Psychopharmacol. (Oxf. Engl.)"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.11.004_bb0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/WNF.0000000000000117","article-title":"Assessing and reporting the adverse effects of antipsychotic medication: a systematic review of clinical studies, and prospective, retrospective, and cross-sectional research","volume":"39","author":"Longden","year":"2016","journal-title":"Clin. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2017.11.004_bb0210","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-200746050-00001","article-title":"Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response","volume":"46","author":"Mauri","year":"2007","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.11.004_bb0215","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2648.2008.04906.x","article-title":"Subjective side effects of antipsychotics and medication adherence in people with schizophrenia","volume":"65","author":"McCann","year":"2009","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.pnpbp.2017.11.004_bb0220","author":"Methodology"},{"issue":"12","key":"10.1016\/j.pnpbp.2017.11.004_bb0225","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"9426","key":"10.1016\/j.pnpbp.2017.11.004_bb0230","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","article-title":"Schizophrenia","volume":"363","author":"Mueser","year":"2004","journal-title":"Lancet (Lond. Engl.)"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2017.11.004_bb0235","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.11.004_bb0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00127-010-0320-1","article-title":"Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective","volume":"47","author":"Nose","year":"2012","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"9690","key":"10.1016\/j.pnpbp.2017.11.004_bb0245","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"van Os","year":"2009","journal-title":"Lancet (Lond. Engl.)"},{"issue":"6","key":"10.1016\/j.pnpbp.2017.11.004_bb0250","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/FTD.0b013e3182708ec5.","article-title":"Therapeutic drug monitoring of common antipsychotics","volume":"34","author":"Patteet","year":"2012","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.11.004_bb0255","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.comppsych.2006.03.008","article-title":"Generalizability studies of the global assessment of functioning-split version","volume":"48","author":"Pedersen","year":"2007","journal-title":"Compr. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.11.004_bb0260","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1586\/14737167.2.4.347","article-title":"Impact of antipsychotic agents and their side effects on the quality of life in schizophrenia","volume":"2","author":"Ritsner","year":"2002","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.11.004_bb0265","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/schbul\/sbr189","article-title":"Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data","volume":"39","author":"Sakurai","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.11.004_bb0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.11.004_bb0275","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jpainsymman.2009.09.008","article-title":"Antipsychotics for acute and chronic pain in adults","volume":"39","author":"Seidel","year":"2010","journal-title":"J. Pain Symptom Manag."},{"issue":"7","key":"10.1016\/j.pnpbp.2017.11.004_bb0280","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4088\/JCP.08r04392","article-title":"Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review","volume":"70","author":"Simon","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.11.004_bb0285","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/schbul\/sbp034","article-title":"Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group","volume":"37","author":"Simonsen","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.pnpbp.2017.11.004_bb0290","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/09540261.2010.515965","article-title":"Gender differences in antipsychotic prescribing","volume":"22","author":"Smith","year":"2010","journal-title":"Int. Rev. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.11.004_bb0295","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.pnpbp.2017.11.004_bb0300","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archpsyc.60.12.1187","article-title":"Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies","volume":"60","author":"Sullivan","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2017.11.004_bb0305","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/JCP.0000000000000569","article-title":"Incidence of antipsychotic-associated side effects: impact of clinician versus patient ratings and change versus absolute scores","volume":"36","author":"Takeuchi","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.11.004_bb0310","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0033291703001107","volume":"34","author":"Trivedi","year":"2004","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.11.004_bb0315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4088\/JCP.08r04171","article-title":"Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms","volume":"70","author":"Uchida","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2017.11.004_bb0320","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1176\/appi.ps.55.8.886","article-title":"Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia","volume":"55","author":"Weiden","year":"2004","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.pnpbp.2017.11.004_bb0325","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.11.004_bb0330","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/0269881114562090","article-title":"\"First do no harm.\"a systematic review of the prevalence and management of antipsychotic adverse effects","volume":"29","author":"Young","year":"2015","journal-title":"J. Psychopharmacol. (Oxf. Engl.)"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617306279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617306279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T08:45:38Z","timestamp":1565340338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584617306279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":66,"alternative-id":["S0278584617306279"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.11.004","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Side effect burden of antipsychotic drugs in real life \u2013 Impact of gender and polypharmacy","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}